Loading…
Smith & Nephew plc is projected to rise to $36.50 by 2027, a +13% move from its current price of $32.33. SNN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/31/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 1 | $31.76 | $32.32 | $32.89 | -0.03% |
| Aug 2 | $31.52 | $32.31 | $33.12 | -0.06% |
| Aug 3 | $31.33 | $32.30 | $33.30 | -0.09% |
| Aug 4 | $31.17 | $32.29 | $33.45 | -0.13% |
| Aug 5 | $31.03 | $32.28 | $33.57 | -0.16% |
| Aug 6 | $30.91 | $32.27 | $33.69 | -0.19% |
| Aug 7 | $30.79 | $32.26 | $33.80 | -0.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $30.79 | $32.26 | $33.80 | -0.22% |
| Week 2 | $30.14 | $32.19 | $34.38 | -0.44% |
| Week 3 | $29.63 | $32.12 | $34.82 | -0.65% |
| Week 4 | $29.20 | $32.05 | $35.18 | -0.87% |
| Week 5 | $28.82 | $31.98 | $35.49 | -1.09% |
| Week 6 | $28.47 | $31.91 | $35.76 | -1.31% |
| Week 7 | $28.15 | $31.84 | $36.01 | -1.52% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Smith & Nephew plc is a healthcare company that develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally. It operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.
The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. It also provides sports medicine joint repair products comprising instruments, technologies, and implants to perform minimally invasive surgery, as well as treating soft tissue injuries and degenerative conditions of the shoulder, knee, hip, and small joints. In addition, it offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions.
Further, the company offers advanced wound care products for the treatment and prevention of acute and chronic wounds, leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, such as biologics and other bioactive technologies for debridement and dermal repair/regeneration, and regenerative medicine products, including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It serves the healthcare providers. Smith & Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom.
Smith & Nephew plc (SNN) is a healthcare company with a global footprint, currently priced at $32.56 and with a market cap of $13.7B, ranking 737. This position reflects its standing within the healthcare device sector and its diversified portfolio across orthopaedics, sports medicine and ENT, and advanced wound management.
The stock’s near-term outlook shows a 30-day forecast around its current level, with a 30-day range of $28.81 to $36.80 and a near-term resistance at $32.56 alongside a support level at $28.73. The current price sits near key moving averages, with the SMA50 at $30.32 and the SMA200 at $32.77, signaling a balance between momentum and value in the short run.
Longer-term forecasts indicate a rising trajectory, beginning with a 2026 average price of $32.56 (min $28.73, max $39.61) and moving higher in subsequent years, reaching an average of $57.72 by 2030, $124.35 by 2040, and $259.52 by 2050. Associated ROIs show a path from 0 in 2026 to 77.3 in 2030, 281.9 in 2040, and 697.1 in 2050, underscoring meaningful upside potential over the horizon.
A major floor 15.5% below — a decisive break under it would weaken the trend.
The nearest floor, 11.1% below — buyers have tended to step in here.
Price is pressing into resistance (1.0% away) — a breakout level to watch.
A major ceiling 8.8% above — clearing it would confirm fresh momentum.
Key SNN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SNN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $31.85 | Buy | $31.91 | Buy |
| MA 10 | $31.02 | Buy | $31.39 | Buy |
| MA 20 | $30.78 | Buy | $30.94 | Buy |
| MA 50 | $30.43 | Buy | $30.78 | Buy |
| MA 100 | $31.24 | Buy | $31.32 | Buy |
| MA 200 | $32.74 | Sell | $31.85 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 61.55 | Neutral |
| Stoch RSI (14) | 84.27 | Sell |
| CCI (20) | 159.08 | Buy |
| Williams %R (14) | -11.42 | Info |
| MACD (12,26,9) | 0.25 | Buy |
| ROC (12) | 8.38 | Buy |
| Bollinger %B (20,2) | 0.96 | Neutral |
| Stochastic %K (14) | 88.58 | Sell |
| TRIX (15) | 0.09 | Buy |
| Awesome (5,34) | 1.40 | Buy |
| Ultimate (7,14,28) | 70.52 | Sell |
| Momentum (10) | 0.92 | Buy |
| Aroon Osc (25) | 76.00 | Buy |
| Hull MA (9) | 32.91 | Sell |
| ADX (14) | 12.08 | Neutral |
| ATR (14) | 0.51 | Info |
Near term, the sentiment is BULLISH with an RSI14 of 60. The stock trades with a SMA50 of $30.32 and a SMA200 of $32.77; the current price is $32.56. Support is at $28.73 and resistance at $32.56, with a 30-day price range of $28.81 to $36.80.
These indicators suggest the stock has room to test the nearby resistance while preserving a cushion above the established support levels, and that momentum is positive but not extreme given the RSI level.
The combination of a bullish sentiment and a price close to the SMA200 implies potential for continued upward movement, particularly if momentum sustains above the near-term baselines. Traders may watch for a breakout above $32.56 or a retreat toward support near $28.73 for clues about the next directional move.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $28.73 | $32.33 | $39.37 | 0% | Neutral | |
| $29.93 | $36.50 | $46.52 | +13% | Neutral | |
| $34.63 | $43.04 | $56.36 | +33% | Bullish | |
| $38.12 | $48.11 | $64.35 | +49% | Bullish | |
| $45.26 | $57.90 | $78.85 | +79% | Bullish | |
| $50.01 | $64.77 | $89.61 | +100% | Bullish | |
| $50.87 | $66.62 | $93.49 | +106% | Bullish | |
| $54.47 | $72.09 | $102.49 | +123% | Bullish | |
| $56.32 | $75.28 | $108.30 | +133% | Bullish | |
| $62.47 | $84.29 | $122.63 | +161% | Bullish | |
| $89.98 | $126.65 | $193.11 | +292% | Bullish | |
| $175.70 | $265.26 | $433.58 | +720% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $28.73 | $32.33 | $37.65 | +0.00% |
| August 2026 | $27.36 | $31.91 | $37.92 | -1.30% |
| September 2026 | $26.79 | $31.42 | $37.69 | -1.53% |
| October 2026 | $27.20 | $32.04 | $38.72 | +1.99% |
| November 2026 | $27.47 | $32.48 | $39.49 | +1.37% |
| December 2026 | $27.15 | $32.21 | $39.37 | -0.83% |
Click any year to see its month-by-month SNN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Smith & Nephew plc's 2026 outlook centres on $32.33, within a $28.73 to $39.37 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, SNN could reach as high as $46.52, with a base case around $36.50 and support toward $29.93 — roughly +13% from $32.33. A consolidation phase looks the most probable path here.
Expect SNN to range from $34.63 to $56.36 through 2028. The $43.04 average target implies a +33% move from current prices. That is up +18% on the projected 2027 average. Momentum favours further upside here.
The SNN price prediction for 2029 points to an average of $48.11 (low $38.12, high $64.35) — a potential gain of +49% on today's $32.33. Buyers look set to stay in control over this stretch.
In 2030, SNN is projected to trade between $45.26 and $78.85, averaging $57.90 — a potential gain of +79% from today's $32.33. That is up +20% on the projected 2029 average. Momentum favours further upside here.
Smith & Nephew plc's 2031 outlook centres on $64.77, within a $50.01 to $89.61 range. That is up +12% on the projected 2030 average. That marks a +100% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, SNN could reach as high as $93.49, with a base case around $66.62 and support toward $50.87 — roughly +106% from $32.33. Momentum favours further upside here.
Expect SNN to range from $54.47 to $102.49 through 2033. The $72.09 average target implies a +123% move from current prices. That is up +8% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The SNN price prediction for 2034 points to an average of $75.28 (low $56.32, high $108.30) — a potential gain of +133% on today's $32.33. Momentum favours further upside here.
In 2035, SNN is projected to trade between $62.47 and $122.63, averaging $84.29 — a potential gain of +161% from today's $32.33. That is up +12% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Smith & Nephew plc's 2040 outlook centres on $126.65, within a $89.98 to $193.11 range. That is up +50% on the projected 2035 average. That marks a +292% change versus current levels. Momentum favours further upside here.
By 2050, SNN could reach as high as $433.58, with a base case around $265.26 and support toward $175.70 — roughly +720% from $32.33. Buyers look set to stay in control over this stretch.
Investing $1,000 in SNN today (≈ 30.931024 SNN) could be worth
$8,204.73
+$7,204.73 (+720%) by 2050 · US Dollar
Based on the average projected SNN price of $265.26 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SNNwould be worth at today's price.
$1,000 invested in SNN on Jul 30, 2025 (≈ 32.33107 SNN) would be worth
$1,045.26
+$45.26 (+4.5%) today · 1.05× · US Dollar
Based on a SNN entry price of $30.93 vs. today's $32.33.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $29.77 | $1,085.99 | +8.6% |
| 1 month ago | $28.81 | $1,122.18 | +12.2% |
| 3 months ago | $31.16 | $1,037.55 | +3.8% |
| 6 months ago | $34.14 | $946.98 | -5.3% |
| 1 year ago | $30.93 | $1,045.26 | +4.5% |
| All time (5.0y) ago | $39.65 | $815.38 | -18.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SNN forecast.
Our base-case forecast reaches $65.00 around 2032.
Implied market cap at $65.00: $27.32B
The multi-year forecast shows a clear upward trajectory through 2035 and beyond. The 2026 avg is $32.56 with a min of $28.73 and a max of $39.61, ROI 0, sentiment NEUTRAL, followed by rising averages: 2027 avg $36.68, 2028 avg $43.01, 2029 avg $47.90, 2030 avg $57.72 (ROI 77.3), 2031 avg $64.39, 2032 avg $66.00, 2033 avg $71.49, 2034 avg $74.45, 2035 avg $83.12. The forecast continues to climb to 2040 avg $124.35 (ROI 281.9) and 2050 avg $259.52 (ROI 697.1), with bullish sentiment in the later years.
These projections imply meaningful upside from today’s level, but they are estimates and carry inherent uncertainty. The numbers suggest a steady uplift over time, with substantial potential in the 2030s and 2040s, tempered by the usual market risks and fluctuations that can affect equity prices in the healthcare sector.
Tap a question to reveal the answer.
Avg $57.72, Min $45.11, Max $78.61, ROI 77.3, Sentiment BULLISH.
Forecasts show positive upside across multiple years, with Avg prices rising to $57.72 by 2030 and up to $259.52 by 2050; ROIs reach 77.3 (2030), 281.9 (2040), and 697.1 (2050). These are estimates and not guarantees.
Yes. The forecast max for 2033 is $101.63.
Min $88.34, Avg $124.35, Max $189.61, ROI 281.9, Sentiment BULLISH.
Smith & Nephew plc Community Discussion
0Share your Smith & Nephew plc price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.